Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
Loren Pickart in 1973 from human plasma albumin, this compound sparked over four decades of research into its remarkable regenerative properties
2022 Apr 11;13(1):159
Others are synthesized by the body and are therefore "non-essential", like Vitamin D for example
More recently, its ability to stimulate hair follicles, improve scalp circulation, and create a healthier growth environment has made it a promising candidate for hair restoration
Tissue repair depends on timing, load management, inflammatory control, nutrition, sleep, and the accuracy of the original diagnosis